Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. IRON
IRON logo

IRON

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IRON News

Disc Medicine Faces Investigation Over Disclosure Failures Amid 21.9% Stock Drop

5d agoPRnewswire

Disc Medicine Under Investigation for Securities Fraud

6d agoGlobenewswire

Rosen Law Firm Investigates Securities Claims for Disc Medicine Shareholders

6d agoGlobenewswire

Rosen Law Firm Investigates Securities Claims for Disc Medicine Shareholders

Mar 21 2026Globenewswire

Rosen Law Firm Investigates Securities Claims for Disc Medicine Shareholders

Mar 20 2026PRnewswire

Disc Medicine Under Investigation for Securities Violations Amid FDA Concerns

Mar 18 2026Globenewswire

Disc Medicine Faces Investor Scrutiny After FDA Response Letter

Mar 18 2026Newsfilter

Disc Medicine Faces FDA Investigation Risks Following CRL

Mar 17 2026Newsfilter

Investigation into Disc Medicine's 21.9% Stock Collapse

Mar 11 2026Newsfilter

Chronic Kidney Disease Market Growth Drivers

Mar 03 2026Newsfilter

Pomerantz LLP Investigates Claims on Behalf of Disc Medicine Investors

Mar 03 2026Globenewswire

Disc Medicine CFO Sells 11,156 Shares Amid FDA Rejection

Mar 01 2026Fool

Disc Medicine CFO Sells Shares, Reduces Holdings

Mar 01 2026NASDAQ.COM

Disc Medicine Initiates Restructuring Plan with 20% Layoffs

Feb 27 2026seekingalpha

Disc Medicine Reports FY Loss and Cash Position Improvement

Feb 26 2026seekingalpha

BVF Acquires New Position in Disc Medicine

Feb 25 2026Fool